Cruise stocks rally after FDA approval of Pfizer COVID-19 vaccine

  • 📰 MarketWatch
  • ⏱ Reading Time:
  • 20 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 11%
  • Publisher: 97%

Business News News

Business Business Latest News,Business Business Headlines

Cruise stocks among those rallying on first full COVID vaccine approval by FDA

Shares of cruise operators rallied Monday, as the Food and Drug Administration's full approval of the COVID-19 vaccine developed by Pfizer Inc. PFE, +2.92% and partner BioNTech SE BNTX, +8.77% boosted hopes for increased vaccination rates. Carnival Corp.'s stock CCL, +2.69% ran up 2.6%, Norwegian Cruise Line Holdings Ltd.

shares climbed 3.0% and Royal Caribbean Group GRP, -0.85% tacked on 1.1%. In comparison, the S&P 500 SPX, +0.96% advanced 0.9%. The companies have required its staff and guests on most of their cruises to be vaccinated. Acting FDA Commissioner Janet Woodcock said the FDA approval of the Pfizer-BioNTech vaccine"may now instill additional confidence to get vaccinated."

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 3. in BUSÄ°NESS

Business Business Latest News, Business Business Headlines